DXVX Extends Supply Contract for Healthcare Products with OFMEIGHT Trading, Securing 5.6 Billion KRW Revenue Stream Through 2028

DXVX has extended the supply contract for its Obmam series healthcare products with OFMEIGHT TRADING, a Vietnamese health and beauty distributor, through 2028.
The contract value is approximately 5.6 billion KRW, representing 12% of 2023 revenue, with no conditional elements.
The extension strengthens an existing business relationship without any capital raising, resulting in no dilution for shareholders.
[AI Summary]The contract extension enhances revenue stability for DXVX but does not introduce new growth catalysts or capital changes, resulting in a neutral impact on shareholder value.